SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-04-000015
Filing Date
2004-08-05
Accepted
2004-08-05 17:13:04
Documents
6
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 06/30/04 10Q ligand060410q.htm 10-Q 405790
2 EXHIBIT 3.6 ex3-6.txt EX-3.(I) 4612
3 EXHIBIT 31.1 ex31-1.txt EX-31 3124
4 EXHIBIT 31.2 ex31-2.txt EX-31 3114
5 EXHIBIT 32.1 ex32-1.txt EX-32 1836
6 EXHIBIT 32.2 ex32-2.txt EX-32 1813
  Complete submission text file 0000886163-04-000015.txt   422332
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 04955461
SIC: 2834 Pharmaceutical Preparations